These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The electrophysiologist and the cardiac surgeon. Samuels LE; Samuels FL Adv Card Surg; 2000; 12():97-115. PubMed ID: 10949646 [No Abstract] [Full Text] [Related]
26. Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Pacemaker Implantation). Dreifus LS; Fisch C; Griffin JC; Gillette PC; Mason JW; Parsonnet V J Am Coll Cardiol; 1991 Jul; 18(1):1-13. PubMed ID: 2050911 [No Abstract] [Full Text] [Related]
27. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. Mirowski M; Reid PR; Mower MM; Watkins L; Gott VL; Schauble JF; Langer A; Heilman MS; Kolenik SA; Fischell RE; Weisfeldt ML N Engl J Med; 1980 Aug; 303(6):322-4. PubMed ID: 6991948 [No Abstract] [Full Text] [Related]
28. Implantable devices for the treatment of cardiac arrhythmias. Luceri RM; Castellanos A; Myerburg RJ Med Instrum; 1986; 20(5):277-84. PubMed ID: 3784935 [TBL] [Abstract][Full Text] [Related]
29. [Rational treatment of cardiac arrhythmias. I. Therapeutic agents and methods]. Georgescu G Rev Med Chir Soc Med Nat Iasi; 1984; 88(2):251-62. PubMed ID: 6544999 [No Abstract] [Full Text] [Related]
32. [Possibilities of electrotherapy of the heart in the prehospital phase]. Volkmann H; Paliege R Z Arztl Fortbild (Jena); 1984; 78(15):623-5. PubMed ID: 6495772 [No Abstract] [Full Text] [Related]
34. Current role of the automatic implantable cardioverter-defibrillator in the treatment of life-threatening ventricular arrhythmias. Kay GN; Plumb VJ; Dailey SM; Epstein AE Am J Med; 1990 Jan; 88(1N):25N-34N. PubMed ID: 2195882 [TBL] [Abstract][Full Text] [Related]
35. Serial lead impedance measurements confirm fixation of helical screw electrodes during pacemaker implantation. Roelke M; Bernstein AD; Parsonnet V Pacing Clin Electrophysiol; 2000 Apr; 23(4 Pt 1):488-92. PubMed ID: 10793439 [TBL] [Abstract][Full Text] [Related]
37. The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias. Kelly PA; Cannom DS; Garan H; Mirabal GS; Harthorne JW; Hurvitz RJ; Vlahakes GJ; Jacobs ML; Ilvento JP; Buckley MJ J Am Coll Cardiol; 1988 Jun; 11(6):1278-86. PubMed ID: 3367002 [TBL] [Abstract][Full Text] [Related]
38. Usefulness of placement of intraoperative epicardial wires during automatic implantable cardioverter-defibrillator insertion to preclude the need for transvenous catheters at the predischarge electrophysiology study. Smith PN; Schumitsch PA; Seebandt ML; Bores CJ; Weiler ET; Ray JF; Myers WO; Douglas-Jones JW; Vidaillet HJ Am J Cardiol; 1991 Sep; 68(6):679-81. PubMed ID: 1877489 [No Abstract] [Full Text] [Related]
39. Management of malignant ventricular arrhythmias using antitachycardia devices. McCowan RJ; Sampath R; Lee KC; Rashid H; Cafoncelli AR; Khan ZM; Malik FS; Chapman JL; Figueroa E; Freund PE W V Med J; 1991 Sep; 87(9):395-9. PubMed ID: 1949755 [TBL] [Abstract][Full Text] [Related]
40. [Transcutaneous cardiac pacemaker for prevention and emergency therapy in neurologic intensive care patients]. Hilz MJ; Claus D; Bauer J; Neundörfer B Nervenarzt; 1990 Dec; 61(12):744-8. PubMed ID: 2079989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]